Clopidogrel vs aspirin after heart stent treatment
Part of Heart & circulation clinical trials.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You recently received a zotarolimus-eluting Onyx drug-eluting heart stent for ischemic (reduced blood flow) heart disease
- You can sign and understand the informed consent form
- You are younger than 85 years old
- You do NOT currently have an acute heart attack
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood-thinning medicines—ticagrelor and clopidogrel—after you’ve already had a drug-eluting stent placed for a heart attack. It aims to see which option better prevents new heart-related events in people at higher risk.
This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.
This trial tests whether tailoring anti-platelet (blood clot prevention) treatment can better protect people at higher risk of heart or blood-vessel problems after a drug-eluting stent. It may help prevent future clots and complications, especially in patients with certain high-risk health conditions or complex stent/scar tissue features.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
This study looks at whether taking two blood thinners (aspirin and clopidogrel) helps people who have had a stent placed to open a long-term total blockage in a heart artery. If you had a successful procedure to open such a blockage and are able to take aspirin, this trial might be for you.
This trial is testing whether lowering the dose of your current blood thinner or switching to a different one (clopidogrel) is safer and works just as well after you've had a stent placed. It's designed for people who are already on two blood thinners and are doing well.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.